Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study
- 1 May 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 105 (5), e52-e53
- https://doi.org/10.1097/tp.0000000000003637
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 5 references indexed in Scilit:
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationJCI Insight, 2020
- SARS-CoV-2 viral dynamics in immunocompromised patientsAmerican Journal of Transplantation, 2020
- Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, TennesseeJama-Journal Of The American Medical Association, 2020
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationPublished by Cold Spring Harbor Laboratory ,2020
- Convalescent Plasma to Treat COVID-19 Possibilities and ChallengesJama-Journal Of The American Medical Association, 2020